FREDERICK, Md., March 17, 2025 /PRNewswire/ -- Theradaptive, a privately held, clinical-stage biologics company developing targeted protein therapeutics is pleased to announce the appointment of Jeffrey W. Dunn to its Board of Directors. Mr. Dunn brings over three decades of leadership...
Read More Details
Finally We wish PressBee provided you with enough information of ( Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors )
Also on site :
- Market Outlook for the Week 17th - 21st March
- Explosion near security zone in Damascus
- Local Government Meetings: March 17-21, 2025